Fri, Jul 11, 2014, 11:42 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Kinder Morgan Energy Partners, L.P. Message Board

jad9000 212 posts  |  Last Activity: Jul 10, 2014 5:43 PM Member since: Nov 3, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    #$%$ Cramer

    by mudpuddle52 Jul 2, 2014 9:13 PM
    jad9000 jad9000 Jul 3, 2014 12:08 AM Flag

    Cramers record is matched by picking either red or black on a roulette wheel. He's a total moron.

    Sentiment: Strong Buy

  • Reply to

    Pied PIpers says

    by terry_insm Apr 24, 2014 1:33 PM
    jad9000 jad9000 Apr 24, 2014 11:24 PM Flag

    The company has more than enough cash to get to sales. I doubt they want to do another raise. They can increase their credit facility with Hercules by another $30 to $50 million or so. They can sign a partner deal for Asia and negotiate a $50 million upfront payment or more. As they indicated, if they have to do a phase 3 it would be "short", In fact, their current extension of the phase 2 is a de facto phase 3 anyway. Piper can read the tea leaves. They are ramping up, Piper has seen the ongoing data including more culture negative patients, more patient improvement,, any possible regressions, etc.

    Sentiment: Strong Buy

  • Reply to

    Longs get their comeuppance

    by l_thurow Apr 29, 2014 11:39 AM
    jad9000 jad9000 Apr 29, 2014 12:31 PM Flag

    Total nonsense. For a year it has been all about declining book value driving justifying the drop in the share price Now book value is ratcheting up, and will continue to ratchet up, and now it's about earnings. We will now see leverage increase, earning increase and book value increase - and soon to follow, distributions will increase. This is the classic trader/short ploy of sell on the news as shorts cover their positions. The share price will be up at least 30% by year end and the distributions will be at least $.80 per quarter.

    Sentiment: Strong Buy

  • Reply to

    A little twist from this past week

    by justarook04 Jun 22, 2014 11:33 AM
    jad9000 jad9000 Jun 22, 2014 12:01 PM Flag

    All it's going to take is a press release about continued cures for patients, any potential partnerships, filing for cf/ntm in Europe, etc. Then, in come the momentum crowd. With such a low float, institutional buyers outnumbering sellers, short covering and retail buyers stepping in the "analysts" will be forced to upgrade. I expect the average to be in the 40's by mid-July - and climbing to the 60's by yearend.

    Sentiment: Strong Buy

  • Reply to

    Late Breaking

    by biowatchdog May 16, 2014 1:10 PM
    jad9000 jad9000 May 16, 2014 1:27 PM Flag

    It is now clear that Arikayce is a better and safer product than Tobi for CF and should assume the role of primary therapy. Add to this it being the only drug to substantially cure NTM and we have a blockbuster. There will be lots of analysts at the conference and next week to party starts.

    Sentiment: Strong Buy

  • Reply to

    NEWEST Short Interest.....

    by insmhistorian Jun 10, 2014 4:24 PM
    jad9000 jad9000 Jun 10, 2014 10:29 PM Flag

    So, it took churning day in and day out as well as 750,000 shorted shares to keep a lid on the share price in May. We can see from the current average daily volume just how much illegal churning there was when they were forcing down the share price - almost 650,000 shares of daily churning and fake volume.

    Sentiment: Strong Buy

  • Reply to

    Only one thing left to prove: regulatory success.

    by jsblvbjb May 13, 2014 2:27 PM
    jad9000 jad9000 May 13, 2014 3:15 PM Flag

    The short volume ratio has been well over 50% over the past 5 days - 61% yesterday. There is a pretty concerted effort to keep the share price from running. I'm guessing we will be over 50% again today. Nobody selling - just a bunch of shorting. To what end I don't know because the risk is clearly on the short side and not for longs.

    Sentiment: Strong Buy

  • Reply to

    There is no stock to buy

    by zake1 Apr 25, 2014 10:55 AM
    jad9000 jad9000 Apr 26, 2014 1:02 PM Flag

    First of all, UBS never downgraded Insmed, per the company's IR folks after the supposed downgrade was issued. It was a spoof that the reporting sites quickly reversed. Fidelity has another "downgrade" listed as well from McLean (a one man shop in Sarasota Florida that is irrelevant). Clearly Fidelity's fund managers don't care a lot about these either non-existent or irrelevant downgrades. Wedbush is likely bought and paid for and any credibility that may have had at one time has eroded quickly as test results are announced. They have been proven to be completely wrong in their assessment. We likely have a hedge fund piling on shorts to drive down the sp and pick up stop losses and any retail shares that are available from spooked investors and any existing institutions who decided to pare their biotech holdings during the bear raid on the sector. I think this strategy is now backfiring and bringing in more retail buying, as witnessed by the fact that they had to short 63% of total shares transacted on Friday to drive down the price. This ration is twice as high as the daily average over the past couple of months. I think we will see that institutional ownership has climbed above 90% now. I also think that the million shares owned by "strategic" investors are owned by big pharma that are watching the activity and results coming out. I suspect that if Insmed announces a partnership with one of the Japanese pharma companies for marketing in Asia or breakthrough therapy designation is give it will force action from whatever big pharma(s) are in the hunt. And, I can't fathom that, as Arkayce has delivered a cure to 24% of afflicted NTM patients in just 12 weeks (and no other product exists for any cure of said same), this designation will not be granted. We will see soon enough.

    Sentiment: Strong Buy

  • Reply to

    Shares available to short

    by jad9000 May 27, 2014 10:52 AM
    jad9000 jad9000 May 27, 2014 12:26 PM Flag

    Who knows - the two may in fact be one.

    Sentiment: Strong Buy

  • Strategic investors hold at least a million shares. I wonder if the petition to not disclose info made to the SEC has to do with hiding the name of the strategic owner of those shares. If it is a big pharma it would set off a bidding war sooner than later and drive up the cost for either a partnership or an acquisition. I also wonder if the strategic now exceeds the 5% threshold of ownership for this same disclosure which would trigger a mandatory SEC filing.

    Sentiment: Strong Buy

  • Reply to

    There is no stock to buy

    by zake1 Apr 25, 2014 10:55 AM
    jad9000 jad9000 Apr 26, 2014 7:33 PM Flag

    shortvolumedotcom

    Sentiment: Strong Buy

  • A month ago there were 2,700,000 shares available to short. Today there are 950,000. I suspect that institutional investors have taken retail shares and made them unavailable for shorting or have closed the shorts they have on their own shares. Short interest numbers will also be interesting to see for the May 15th period.

    Sentiment: Strong Buy

  • Reply to

    Now What?

    by bigbear.2010 May 9, 2014 9:54 AM
    jad9000 jad9000 May 9, 2014 1:25 PM Flag

    the average daily shorting is over 50% this week and almost 60% yesterday. This is the continuation of a bear raid by hedge funds who don't care about facts and engage in collusion to drive the price depending on whether they are long or short. It all ends with earnings and, likely, a spike in the sp as we approach earnings. Fundamentals are no longer the foundation of the stock market - the foundation is manipulation. Wall Street and our government no longer have the respect or faith from the people. That is the bigger issue.

    Sentiment: Strong Buy

  • Reply to

    Not so fast

    by boardhead_99 Jun 22, 2014 2:27 PM
    jad9000 jad9000 Jun 22, 2014 3:14 PM Flag

    Nonsense. Have that conversation with the 34% plus that went culture negative in 12-24 weeks. Also, go talk to the FDA and explain how you're the expert and they are not. Good luck with that. Bottom line - better cover on Monday.

    Sentiment: Strong Buy

  • Reply to

    Possible scenario behind the $51 PT by Schimmer

    by justarook04 Apr 24, 2014 2:48 PM
    jad9000 jad9000 Apr 24, 2014 3:07 PM Flag

    Assuming NTM is approved in both the US and EU - and this giving approval to countries globally - what is the global market and what is the value of a treatment regimen. My understanding is that the global market is around 350,000. 1/3 market penetration would be around 100,000 per year. If the treatment regimen is $16,000 x 4 cycles it equates to about $64,000 per patient or close to $6,4 billion in revenues. If market penetration is half of this and treatment is half, this still yields $1.6 billion per year. Add in CF and possibly another $400 million annually, or around $2 billion. Net present value would take this down to around $1.4 billion with an additional $$300 million net present value for Iplex and short stature. $1.7 billion x 6 (average biotech multiple) equates to around a $10 billion valuation, or $250 per share. I believe that, by yearend this will be the net present value.

    Sentiment: Strong Buy

  • Reply to

    Shares available to short

    by jad9000 May 27, 2014 10:52 AM
    jad9000 jad9000 May 27, 2014 11:37 AM Flag

    Have you noticed that almost all of the time that terry posts multiple thumbs down appear on other posts that he's disagreeing with. I've seen as many as six thumbs down appear at once when he shows up. What a weirdo.

    Sentiment: Strong Buy

  • Reply to

    There is no stock to buy

    by zake1 Apr 25, 2014 10:55 AM
    jad9000 jad9000 Apr 25, 2014 11:55 AM Flag

    Between the tutes, option holders and individual owners from prior management there are no shares available so they just churn the stock to try to shake loose something - which isn't working. There are still millions of shares short that they can't cover do to lack of shares available at anything close to this price. The April numbers had buyers over sellers at 12 to 1. This isn't rocket science. Very soon shorts will be forced to cover and then watch out.

    Sentiment: Strong Buy

  • Reply to

    05/29/ 2014 David Brennan to board of directors

    by levonchiko May 29, 2014 9:44 AM
    jad9000 jad9000 May 29, 2014 11:33 AM Flag

    He will be key to establishing marketing partnerships globally - potentially with AZ or others. He is connected. And, he will likely be a great asset for developing product partnerships or licensing deals using Insmed's liposome technology is conjuction with other drugs that may cure other ailments. He also does not join boards without a lot of thought as his personal reputation is at risk. He has certainly done his homework on the company and knows what the upside looks like. Win - win - win for the company, shareholders and him.

    Sentiment: Strong Buy

  • Reply to

    Latest Short Interest (5/15/14).....

    by insmhistorian May 27, 2014 4:15 PM
    jad9000 jad9000 May 27, 2014 11:08 PM Flag

    Someone hung their rear out to keep a lid on the share price. That might be the worst $8 million I've seen invested for a while. It makes you wonder who would roll the dice for $8 million to suppress the share price when a positive FDA response for Breakthrough Therapy would roast them for millions and millions. It doesn't seem like a rational bet based on risk & reward. I assume all of the tutes that are owners will see this as well and potentially see an opportunity to screw our short royally.

    Sentiment: Strong Buy

  • Reply to

    Why I Shorted

    by johnnyporkchop2000 Jun 25, 2014 11:13 AM
    jad9000 jad9000 Jun 25, 2014 11:47 AM Flag

    Again, nobody cares what you think and, so far, neither does the share price. Upside now is infinitely higher than downside, so take your pennies and lose dollars.

    Sentiment: Strong Buy

KMP
81.27+0.07(+0.09%)Jul 11 4:01 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Potbelly Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT
ACI Worldwide, Inc.
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT
MGIC Investment Corp.
NYSEFri, Jul 11, 2014 4:01 PM EDT